News

Upperton Pharma Solutions is a winner in the Business Expansion category in the 2025 Pharmaceutical Excellence Awards.
Philadelphia-based biotech Vivodyne has raised $40 million in series A funding to advance its fully robotic, AI-powered ...
Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...
The pharmaceutical company is evaluating all options to increase its presence in therapy areas, including in-licensing ...
As geopolitical tensions prompt global pharmaceutical giants to pivot away from China, India's Contract Development and ...
The European Commission plans to create a public-private fund of at least 10 billion euros ($11.3 billion) to help tech ...
Peter DeYoung, CEO at Piramal Pharma Limited, explains how Piramal is meeting the growing demand for integrated biologics ...
The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study in neuropathic pain, and finalizes filings for SKNY acquisition.
Data compiled by fund manager Aberdeen and broker Peel Hunt show 61 firms, worth a combined £12.3bn, have announced plans to ...
Company Has Initiated FINRA Process to Complete Rebranding and Ticker Update NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bionoid Pharma, Inc. (OTC PINK:BINP) ("Bionoid" or the "Company") is ...
The company licenses the patented and ... Up Tunable High-Frequency Microwave Heating for Pharmaceutical and Biologics Manufacturing.” It aims to build the core knowledge needed to successfully scale ...
They will tell you they invested heavily in evidence-based approaches and programs for teaching reading—the “science of ...